EU officials outline major pharmaceutical legislative reforms at RAPS Convergence 2026

At RAPS Convergence 2026 in Charlotte, North Carolina, officials from the European Commission and the European Medicines Agency presented a set of reforms aimed at overhauling the European Union’s pharmaceutical legislation.

The proposed changes seek to streamline the drug approval process, improve patient access to medicines, and strengthen safety monitoring while encouraging innovation across the sector.

The officials described the reforms as a comprehensive update to the current framework and indicated that the proposal will now move through the EU’s legislative procedures for adoption.